Kleespies A - Search Results

1

Vascular endothelial growth factor in esophageal cancer.

Kleespies A, Guba M, Jauch KW, Bruns CJ. Kleespies A, et al. J Surg Oncol. 2004 Aug 1;87(2):95-104. doi: 10.1002/jso.20070. J Surg Oncol. 2004. PMID: 15282704 Review.

2

Vascular endothelial growth factor in colorectal cancer.

Guba M, Seeliger H, Kleespies A, Jauch KW, Bruns C. Guba M, et al. Among authors: kleespies a. Int J Colorectal Dis. 2004 Nov;19(6):510-7. doi: 10.1007/s00384-003-0576-y. Epub 2004 Mar 4. Int J Colorectal Dis. 2004. PMID: 14999511 Review.

3

Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies.

Kleespies A, Bruns CJ, Jauch KW. Kleespies A, et al. Onkologie. 2005 May;28(5):281-8. doi: 10.1159/000085198. Epub 2005 Apr 29. Onkologie. 2005. PMID: 15867486 Free article.

4

Cancer stem cells and angiogenesis.

Zhao Y, Bao Q, Renner A, Camaj P, Eichhorn M, Ischenko I, Angele M, Kleespies A, Jauch KW, Bruns C. Zhao Y, et al. Among authors: kleespies a. Int J Dev Biol. 2011;55(4-5):477-82. doi: 10.1387/ijdb.103225yz. Int J Dev Biol. 2011. PMID: 21732274 Free article. Review.

5

Surgery for metastasis to the pancreas: is it safe and effective?

Niess H, Conrad C, Kleespies A, Haas F, Bao Q, Jauch KW, Graeb C, Bruns CJ. Niess H, et al. Among authors: kleespies a. J Surg Oncol. 2013 Jun;107(8):859-64. doi: 10.1002/jso.23333. Epub 2013 May 1. J Surg Oncol. 2013. PMID: 23637007

6

Angiogenesis in cancer: molecular mechanisms, clinical impact.

Eichhorn ME, Kleespies A, Angele MK, Jauch KW, Bruns CJ. Eichhorn ME, et al. Among authors: kleespies a. Langenbecks Arch Surg. 2007 May;392(3):371-9. doi: 10.1007/s00423-007-0150-0. Epub 2007 Feb 16. Langenbecks Arch Surg. 2007. PMID: 17458577 Review.

7

Contrast enhanced MRI and intravital fluorescence microscopy indicate improved tumor microcirculation in highly vascularized melanomas upon short-term anti-VEGFR treatment.

Eichhorn ME, Strieth S, Luedemann S, Kleespies A, Nöth U, Passon A, Brix G, Jauch KW, Bruns CJ, Dellian M. Eichhorn ME, et al. Among authors: kleespies a. Cancer Biol Ther. 2008 Jul;7(7):1006-13. doi: 10.4161/cbt.7.7.5997. Epub 2008 Mar 29. Cancer Biol Ther. 2008. PMID: 18398295

8

Src tyrosine kinase inhibition suppresses lymphangiogenesis in vitro and in vivo.

Ischenko I, Seeliger H, Camaj P, Kleespies A, Guba M, Eichhorn ME, Jauch KW, Bruns CJ. Ischenko I, et al. Among authors: kleespies a. Curr Cancer Drug Targets. 2010 Aug;10(5):546-53. doi: 10.2174/156800910791517181. Curr Cancer Drug Targets. 2010. PMID: 20370688

9

Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models.

Kleespies A, Köhl G, Friedrich M, Ryan AJ, Barge A, Jauch KW, Bruns CJ. Kleespies A, et al. Neoplasia. 2005 Oct;7(10):957-66. doi: 10.1593/neo.05304. Neoplasia. 2005. PMID: 16242078 Free PMC article.

10

Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?

Kleespies A, Jauch KW, Bruns CJ. Kleespies A, et al. Drug Resist Updat. 2006 Feb-Apr;9(1-2):1-18. doi: 10.1016/j.drup.2006.02.002. Epub 2006 Apr 18. Drug Resist Updat. 2006. PMID: 16621676 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page